Inhibikase Therapeutics Inc (IKT)
Cost of Revenue
$0.00
TTM · Period ending: · USD
IKT Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
IKT TTM Cost of Revenue ($2.98M → $0.00)
TTM cost of revenue
High-resolution chart · PNG
IKT cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 6,567 | |
| 13,135 | |
| 19,704 | |
| 26,272 | |
| 26,273 | |
| 26,273 | |
| 178,908 | |
| 177,383 | |
| 175,857 | |
| 170,970 | |
| 2,993,949 | |
| 6,005,897 | |
| 9,391,113 | |
| 12,543,985 | |
| 11,944,235 | |
| 11,359,104 | |
| 8,195,790 | |
| 5,161,806 | |
| 3,042,548 | |
| 893,802 | |
| 934,773 | |
| 1,069,171 | |
| 1,280,043 | |
| 2,552,710 | |
| 3,629,872 | |
| 3,960,196 | |
| 4,283,548 | |
| 2,984,657 |